Insider Transactions Reported by 13 Insiders of Veradermics, Inc

Symbol
MANE on NYSE
Location
New Haven, CT

Sponsored

Quick Takeaways

  • MANE - Veradermics, Inc has 13 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are available for direct filing-level review.

What Changed

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Why This Matters

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Official SEC Source

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 08 Apr 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Veradermics, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
John W. Childs Director $13,070,559 Mixed 03 Feb 2026
Patrick G. Enright Director, 10%+ Owner Mixed 03 Feb 2026
Vlad Coric Director Mixed 03 Feb 2026
Mark Neumann Chief Commercial Officer, Strategy Officer Mixed 03 Feb 2026
Michael Greco V General Counsel Mixed 03 Feb 2026
Katarina Pance Director Mixed 03 Feb 2026
Reid Alexander Waldman Chief Executive Officer, Director Mixed 03 Feb 2026
Timothy August Durso Chief Technical Officer Mixed 03 Feb 2026
Dominic Gabriel Carrano Chief Financial Officer, Treasurer Mixed 03 Feb 2026
Longitude Capital Partners V, LLC 10%+ Owner Mixed 05 Feb 2026
David Matthew Friedman Director Mixed 03 Feb 2026
M. Grant Kels Director Mixed 03 Feb 2026
SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10%+ Owner Mixed 04 Feb 2026

Top shareholders of Veradermics, Inc (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
John W. Childs
3/4/5
Director
mixed-class rows
345,642
mixed-class rows
$13,070,559 03 Feb 2026
SUVRETTA CAPITAL MANAGEMENT, LLC
13D/G 3/4/5
Director, 10%+ Owner
12%
4,168,991
$0 05 Feb 2026
SR ONE CAPITAL MANAGEMENT, LLC
13D/G
6.4%
2,401,868
$0 05 Feb 2026
VIKING GLOBAL INVESTORS LP
13D/G
5.8%
2,151,493
$0 05 Feb 2026
Patrick G. Enright
3/4/5
Director, 10%+ Owner
mixed-class rows
2,098,605
mixed-class rows
03 Feb 2026
Longitude Capital Partners V, LLC
3/4/5 13D/G
10%+ Owner · Patrick G. Enright
12%
from 13D/G
2,053,474
05 Feb 2026
Reid Alexander Waldman
3/4/5
Chief Executive Officer, Director
mixed-class rows
791,271
mixed-class rows
03 Feb 2026
Vlad Coric
3/4/5
Director
mixed-class rows
500,862
mixed-class rows
03 Feb 2026
Timothy August Durso
3/4/5
Chief Technical Officer
mixed-class rows
448,259
mixed-class rows
03 Feb 2026
Dominic Gabriel Carrano
3/4/5
Chief Financial Officer, Treasurer
class O/S missing
148,011
03 Feb 2026
Michael Greco V
3/4/5
General Counsel
class O/S missing
144,401
03 Feb 2026
Mark Neumann
3/4/5
Chief Commercial Officer, Strategy Officer
class O/S missing
102,885
03 Feb 2026
M. Grant Kels
3/4/5
Director
mixed-class rows
53,980
mixed-class rows
03 Feb 2026
David Matthew Friedman
3/4/5
Director
class O/S missing
43,000
03 Feb 2026
Katarina Pance
3/4/5
Director
class O/S missing
43,000
03 Feb 2026

Recent Insider Transactions by Companies or Individuals for Veradermics, Inc

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Suvretta Capital Management, Llc MANE Common stock, par value $0.00001 per share Purchase 6.23% 30,521 520,453 06 Feb 2026 See footnotes
John W. Childs MANE Common Stock Purchase 294,117 294,117 05 Feb 2026 See Footnote
Suvretta Capital Management, Llc MANE Common stock, par value $0.00001 per share Purchase 24.4% 96,200 489,932 05 Feb 2026 See footnotes
M. Grant Kels MANE Common Stock Conversion of derivative security 2,455 2,455 05 Feb 2026 Direct
M. Grant Kels MANE Series A Convertible Preferred Stock Conversion of derivative security -100% -2,455 0 05 Feb 2026 Direct
Longitude Capital Partners V, LLC MANE Common Stock Purchase 70.5% 1,075,000 2,600,399 05 Feb 2026 See Footnote
Longitude Capital Partners V, LLC MANE Common Stock Conversion of derivative security 3,578,873 2,407,752 05 Feb 2026 See Footnote
Longitude Capital Partners V, LLC MANE Series C Convertible Preferred Stock Conversion of derivative security -100% -2,342,242 0 05 Feb 2026 See Footnote
Longitude Capital Partners V, LLC MANE Series B Convertible Preferred Stock Conversion of derivative security -100% -1,236,631 0 05 Feb 2026 See Footnote
Timothy August Durso MANE Common Stock Conversion of derivative security 1.26% 1,473 118,190 05 Feb 2026 Direct
Timothy August Durso MANE Series A Convertible Preferred Stock Conversion of derivative security -100% -1,473 0 05 Feb 2026 Direct
Reid Alexander Waldman MANE Common Stock Conversion of derivative security 0.62% 1,437 234,872 05 Feb 2026 Direct
Reid Alexander Waldman MANE Series A Convertible Preferred Stock Conversion of derivative security -100% -1,437 0 05 Feb 2026 Direct
Vlad Coric MANE Common Stock Purchase 58.3% 117,646 319,398 05 Feb 2026 See Footnote
Vlad Coric MANE Common Stock Conversion of derivative security 913% 117,112 129,939 05 Feb 2026 Direct
Vlad Coric MANE Common Stock Conversion of derivative security 521,150 260,575 05 Feb 2026 See Footnote
Vlad Coric MANE Series C Convertible Preferred Stock Conversion of derivative security -100% -117,112 0 05 Feb 2026 Direct
Vlad Coric MANE Series C Convertible Preferred Stock Conversion of derivative security -100% -156,150 0 05 Feb 2026 See Footnote
Vlad Coric MANE Series B Convertible Preferred Stock Conversion of derivative security -100% -297,588 0 05 Feb 2026 See Footnote
Vlad Coric MANE Series A Convertible Preferred Stock Conversion of derivative security -100% -67,412 0 05 Feb 2026 See Footnote
Patrick G. Enright MANE Common Stock Purchase 70.5% 1,075,000 2,600,399 05 Feb 2026 See Footnote
Patrick G. Enright MANE Common Stock Conversion of derivative security 3,578,873 2,407,752 05 Feb 2026 See Footnote
Patrick G. Enright MANE Series C Convertible Preferred Stock Conversion of derivative security -100% -2,342,242 0 05 Feb 2026 See Footnote
Patrick G. Enright MANE Series B Convertible Preferred Stock Conversion of derivative security -100% -1,236,631 0 05 Feb 2026 See Footnote
Suvretta Capital Management, Llc MANE Common stock, par value $0.00001 per share Purchase 4.47% 155,953 3,648,538 04 Feb 2026 See footnotes
M. Grant Kels MANE Stock Option (Right to Buy) Award 51,525 51,525 03 Feb 2026 Direct
David Matthew Friedman MANE Stock Option (Right to Buy) Award 43,000 43,000 03 Feb 2026 Direct
Dominic Gabriel Carrano MANE Stock Option (Right to Buy) Award 148,011 148,011 03 Feb 2026 Direct
Timothy August Durso MANE Stock Option (Right to Buy) Award 213,352 213,352 03 Feb 2026 Direct
Reid Alexander Waldman MANE Stock Option (Right to Buy) Award 556,399 556,399 03 Feb 2026 Direct
Katarina Pance MANE Stock Option (Right to Buy) Award 43,000 43,000 03 Feb 2026 Direct
Michael Greco V MANE Stock Option (Right to Buy) Award 144,401 144,401 03 Feb 2026 Direct
Mark Neumann MANE Stock Option (Right to Buy) Award 102,885 102,885 03 Feb 2026 Direct
Vlad Coric MANE Stock Option (Right to Buy) Award 51,525 51,525 03 Feb 2026 Direct
Patrick G. Enright MANE Stock Option (Right to Buy) Award 45,131 45,131 03 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.